Restasis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

A Clinical Study of MIL62 in Primary Membranous Nephropathy
Condition:   Primary Membranous Nephropathy Interventions:   Drug: MIL62;   Drug: Cyclosporine Sponsor:   Beijing Mabworks Biotech Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2022 Category: Research Source Type: clinical trials

Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
Conditions:   Vernal Keratoconjunctivitis;   Cyclosporine 0.05% Eye Drops Interventions:   Drug: Cyclosporine 0.05% eye drops;   Drug: Loteprednol Etabonate 0.5% and Tobramycin Eye Drops 0.3% Sponsor:   Second Affiliated Hospital of Nanchang University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2022 Category: Research Source Type: clinical trials